Back to home
A multicentre, double-blind, randomised, placebo- controlled phase II study to assess efficacy, safety and pharmacokinetics of inhaled Esketamine in subject with treatment-resistant bipolar depression
Forgot your password?
666 069 834
BioStat is responsible for data management and statistical analysis.